Cyclooxygenase-2 overexpression in ovarian endometriomas is associated with higher risk of recurrence

22Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Cyclooxegenase-2 expression was evaluated by immunohistochemistry in endometrioma tissue samples taken from 109 patients, of whom 53 had recurrence by 30 months after surgery and 56 did not. Cyclooxegenase-2 overexpression, along with previous medical treatment of endometriosis and the presence of adhesion, is predictive of recurrence of ovarian endometrioma within 30 months after surgery, with a resultant sensitivity of 72.5% and a specificity of 72.4%, suggesting that there are intrinsic and identifiable biomarkers that confer recurrence risk. © 2009 American Society for Reproductive Medicine.

Cite

CITATION STYLE

APA

Yuan, L., Shen, F., Lu, Y., Liu, X., & Guo, S. W. (2009). Cyclooxygenase-2 overexpression in ovarian endometriomas is associated with higher risk of recurrence. Fertility and Sterility, 91(4 SUPPL.), 1303–1306. https://doi.org/10.1016/j.fertnstert.2008.01.070

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free